Foscarbidopa + Foslevodopa

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
VyalevAU CA US
  • injection ×2 Foscarbidopa 12 mg + Foslevodopa 240 mg
  • unknown Foscarbidopa + Foslevodopa
  • injection Foscarbidopa 120 mg/10 mL + Foslevodopa 2,400 mg/10 mL
ABBVIE CORPORATION
foscarbidopa/foslevodopaAU US12 mg / 240 mgAbbVie Inc.
foslevodopa + foscarbidopaAU ES240 mg/1 mL / 12 mg/1 mL / 2,400 mg/10 mL / 120 mg/10 mLAbbVie Pty Ltd
Produodopa 2.4g/10ml / 120mg/10ml solution for infusion vialsGB
  • injection Foscarbidopa 120 mg/10 mL + Foslevodopa 2,400 mg/10 mL
AbbVie Ltd
Foslevodopa 2.4g/10ml / Foscarbidopa 120mg/10ml solution for infusion vialsGB2,400 mg/10 mL / 120 mg/10 mLAbbVie Ltd
VYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vialAU
  • injection Foscarbidopa 120 mg + Foslevodopa 2,400 mg
Abbvie Pty Ltd
SCYOVA 240 mg/mL + 12 mg/mL, solution pour perfusionFR
  • injection Foscarbidopa 12 mg/1 mL + Foslevodopa 240 mg/1 mL
ABBVIE

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.